This week we speak with Shirin Neshat, one of the most famous contemporary artists from Iran, about the protests in her home country. Shirin’s work focuses on the lives and struggles of Iranian women. The protests have been raging for a month, which, as Shirin says, makes them the longest-running demonstrations since the 1979 Islamic revolution. We talk about what they mean, why this time they’re different, and her art, some of which has been recently projected on buildings in London and Los Angeles. Then, we hear about a new trend in drug research. Scientists can now grow entire human mini-organs in labs. Could that lead to a world without animal testing? The FT’s Clive Cookson and Hannah Kuchler join us to discuss.


Want to stay in touch? We love hearing from you. Email us at ftweekendpodcast@ft.com. We’re on Twitter @ftweekendpod, and Lilah is on Instagram and Twitter @lilahrap.


Links and mentions from the episode:

– Shirin Neshat is on Instagram at @shirin__neshat

– Shirin’s video installation Turbulent, 1998: https://www.youtube.com/watch?v=VCAssCuOGls

– Some photos of Shirin’s Women of Allah series: https://www.matronsandmistresses.com/articles/2021/4/29/shirin-neshat

– Baraye, by Shervin Hajipour https://www.youtube.com/watch?v=TPyHuCZzsVA

– An interview with Shirin in the FT from September 2021: https://on-ft-com.newman.richmond.edu/3zVaVk8

– How science is getting closer to a world without animal testing, by Clive, Hannah and Joe Miller: https://on-ft-com.newman.richmond.edu/3SPlFuA

– Hannah is on Twitter @hannahkuchler, and Clive is on Twitter @clivecookson


Special offers for FT Weekend listeners, from 50% off a digital subscription to a $1/£1/€1 trial can be found here: http://ft.com.newman.richmond.edu/weekendpodcast


Original music by Metaphor Music. Mixing and sound design by Breen Turner and Sam Giovinco

Read a transcript of this episode on FT.com



Hosted on Acast. See acast.com/privacy for more information.

View our accessibility guide.

Copyright The Financial Times Limited 2023. All rights reserved.
Reuse this content (opens in new window) CommentsJump to comments section

Follow the topics in this podcast

Comments

Comments have not been enabled for this article.